Advisor(s)
Abstract(s)
Since the population in the developed world is aging, the burden offragility fractures is aconstantly increasing problem. Despite the fact that potent bone-specific pharmaceutical agents have become available, the problem of how to identify patients with high fracture risk yet remains an enigma. Some studies mention the role of a normal mineral metabolism is critical for skeletal development and preservation of bone integrity. The aim of this study isto investigate the association of mineralmetabolism with hip fractures in type 2 diabetic with chronic
kidney disease (CKD).
Description
Keywords
Citation
Publisher
European Renal Assoc; European Dialysis & Transplant AssocEuropean Renal Assoc; European Dialysis & Transplant Assoc
Oxford University Press
Oxford University Press